%0
Generic
%T
Keynote-365 cohort C: Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC).
%A Fong, Peter C.C.
%A Retz, Margitta
%A Drakaki, Alexandra
%A Massard, Christophe
%A Berry, William R.
%A Romano, Emanuela
%A De Bono, Johann S.
%A Feyerabend, Susan
%A Appleman, Leonard Joseph
%A Conter, Henry Jacob
%A Sridhar, Srikala S.
%A Shore, Neal D.
%A Linch, Mark David
%A Joshua, Anthony
%A Gurney, Howard
%A Wu, Haiyan
%A Schloss, Charles
%A Poehlein, Christian Heinrich
%A Yu, Evan Y.
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2019
%C American Society of Clinical Oncology (ASCO)